ABEONA THERAPEUTICS INC. (ABEO) Pre-Tax Margin
- 2026-06-30: Pre-Tax Margin -177.43%.
- 2026-03-31: Pre-Tax Margin -195.79%.
- 2025-12-31: Pre-Tax Margin -381.46%.
- 2025-06-30: Pre-Tax Margin 31086.25%.
Complete source-backed pre-tax margin history.
- Available history
- 2010-12-31 to 2026-06-30
- Data captured
Historical Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2026-06-30 | -177.43% |
| 2026-03-31 | -195.79% |
| 2025-12-31 | -381.46% |
| 2025-06-30 | 31086.25% |
Annual Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2025-12-31 | 1224.79% |
| 2012-12-31 | -239.15% |
| 2011-12-31 | -136.76% |
| 2010-12-31 | -1566.94% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |